ALSTOM/ADR (OTCMKTS:ALSMY) Receives Average Recommendation of “Buy” from Brokerages

Share on StockTwits

ALSTOM/ADR (OTCMKTS:ALSMY) has been given a consensus recommendation of “Buy” by the six brokerages that are covering the stock, Marketbeat reports. Three investment analysts have rated the stock with a hold recommendation, two have given a buy recommendation and one has assigned a strong buy recommendation to the company.

A number of analysts recently commented on the company. ValuEngine raised ALSTOM/ADR from a “hold” rating to a “buy” rating in a research report on Tuesday, November 5th. Credit Suisse Group initiated coverage on ALSTOM/ADR in a report on Monday, August 19th. They issued a “neutral” rating on the stock. Goldman Sachs Group raised ALSTOM/ADR from a “buy” rating to a “conviction-buy” rating in a research note on Friday, September 13th. Finally, Kepler Capital Markets downgraded ALSTOM/ADR from a “buy” rating to a “hold” rating in a report on Monday, October 21st.

Shares of ALSMY stock traded up $0.08 on Wednesday, reaching $4.32. 2,387 shares of the company were exchanged, compared to its average volume of 10,667. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.13 and a quick ratio of 0.94. The company has a 50-day moving average of $4.21 and a 200-day moving average of $4.30. ALSTOM/ADR has a one year low of $3.80 and a one year high of $4.81.

ALSTOM/ADR Company Profile

Alstom SA develops and markets systems, equipment, and services for the transport sector in Europe, the Americas, Asia and Pacific, the Middle-East, and Africa. The company offers metros, tramways, tram-trains, suburban trains, regional trains, high-speed trains, and passengers and freight locomotives; and signaling products, such as rail control systems, security and control, trackside, and interlocking products.

Further Reading: What is the yield curve?

Analyst Recommendations for ALSTOM/ADR (OTCMKTS:ALSMY)

Receive News & Ratings for ALSTOM/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ALSTOM/ADR and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.